US2011039254A1PendingUtilityA1
Chromosomal Insertion of Gfp Into Bacteria For Quality Control
Est. expirySep 14, 2024(expired)· nominal 20-yr term from priority
C07K 14/43595
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An isolated mutated green fluorescent protein (gfp) gene for chromosomal insertion into a bacterium, wherein the gene is capable of being expressed in bacteria and produce sufficient fluorescence under illumination from a UV lamp in a bacterial colony to be seen by the naked eye. A gene cassette for inserting a gene into a chromosome.
Claims
exact text as granted — not AI-modified1 - 24 . (canceled)
25 . An isolated mutated green fluorescent protein (gfp) gene having mutations at nucleotides positions 1492, 1493 (Ser72Ala), 1737 (Met153Thr) and 1766 (Val163Ala) in the wild-type gfp gene as set out in SEQ ID NO 1, or mutations for synonymous codons which change the same amino acid positions (Ser72Ala, Met153Thr and Val163Ala).
26 . The isolated gene of claim 25 having a nucleic acid sequence from bases 1524 to 2240 as set out in SEQ ID NO 4.
27 . An isolated green fluorescent protein (GFP) expressed by the mutated gfp gene according to claim 25 .
28 . The isolated mutant GFP according to claim 25 comprising one or more mutations of mutant GFP01, mutant GFP02, mutant GFP03, mutant GFP07, mutant GFP10, mutant GFP15, mutant GFP16, mutant GFP20, mutant GFP21, mutant GFP22, mutant GFP26, mutant GFP27, mutant GFP37, mutant GFP43, mutant GFP44, mutant GFP53, mutant GFP54, or mutant GFP55.
29 . The isolated mutant GFP according to claim 27 comprising mutant GFP01, mutant GFP02, mutant GFP03, mutant GFP07, mutant GFP10, mutant GFP15, mutant GFP16, mutant GFP20, mutant GFP21, mutant GFP22, mutant GFP26, mutant GFP27, mutant GFP37, mutant GFP43, mutant GFP44, mutant GFP53, mutant GFP54, or mutant GFP55.
30 . The isolated mutant GFP according to claim 29 having an amino acid sequence as set out in SEQ ID NO 6.
31 . A bacterium or cell containing the mutated gfp gene according to claim 25 .
32 . The bacterium according to claim 31 selected from the group consisting of Acinetobacter lwoffii, Aeromonas hydrophila, Aspergillus niger, Bacillus cereus, Bacillus subtilis, Campylobacter coli, Campylobacter jejuni, Candida albicans, Citrobacter freundii, Clostridium perfringens, Clostridium sporogenes, Edwardsiella tarda, Enterobacter aerogenes, Enterobacter cloacae, Enterococcus faecalis, Escherichia coli, Escherichia coli 0157, Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella aerogenes, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus fermentus, Legionella pneumophila, Listeria innocua, Listeria ivanovii, Listeria monocytogenes, Meth. Resist. Staph. Aureus, Neisseria gonorrhoeae, Proteus rettgeri, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa, Pseudomonas cepacia, Pseudomonas fluorescens, Rhodococcus equi, Salmonella abaetetuba, Saccharomyces cerevisiae, Salmonella salford, Salmonella menston, Salmonella sofia, Salmonella Poona, Salmonella typhimurium, Salmonella poona, Serratia marcescens, Shigella sonnei, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, Vibrio parahaemolyticus, Yersinia enterocolitica, and Zygosaccharomyces rouxii.
33 . The bacterium according to claim 32 being Escherichia coli, Salmonella sp or Listeria sp.
34 . The bacterium according to claim 33 wherein the Salmonella sp is Salmonella typhimurium or Salmonella abaetetuba and the Listeria sp is L. monocytogenes.
35 . The cell according to claim 31 comprising Candida albicans, Zygosaccharomyces rouxii or Aspergillus niger.Join the waitlist — get patent alerts
Track US2011039254A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.